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Another Piece of the Obesity–
Environment Puzzle
Potential Link between Inflammation and POP-
Associated Metabolic Diseases
Epidemiologic research suggests that persistent organic pollutants 
(POPs) in the environment may contribute to the development of 
obesity and features of metabolic diseases, such as elevated triglyc-
eride levels, glucose intolerance, and cardiovascular disease. POPs 
include dioxins and furans—with 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD) being the most potent of these—and polychlorinated biphe-
nyls (PCBs). Due to their lipophilic nature, these compounds accumu-
late in adipose (fat) tissue, the site of many endocrine and metabolic 
functions that are disrupted in metabolic diseases and obesity. A new 
study outlines a mechanism by which inflammation could play a cen-
tral role in POP-associated metabolic disease [EHP 120(4):508–514; 
Kim et al.].
TCDD influences genes underlying various cellular processes by 
binding the aryl hydrocarbon receptor (AhR) and has been shown 
to stimulate production of enzymes involved in the metabolism of 
environmental agents. Other halogenated dioxins and furans, as well 
as coplanar PCBs, may trigger similar effects. 
Inflammation, one of the processes affected by these chemicals, is 
a significant factor in many diseases. Chronic low-grade inflammation 
in adipose tissue alters its biological function, potentially leading to 
insulin resistance and other health problems.
In this study, researchers treated both immature precursor cells and 
mature adipocytes (fat cells) that developed from them with TCDD, 
dioxin-like PCB126, and non–dioxin-like PCB153. For the in vivo 
portion of the study, wild-type and AhR knockout mice were injected 
with a single dose of TCDD or corn oil (control). 
 Mouse adipose tissue was examined after treatment to determine 
the size of the adipocytes and the presence of macrophages (an 
indication of inflammation). Gene expression analysis determined the 
numbers and types of up- and downregulated genes in both cultured 
cells and adipose tissue, with those involved in inflammation being the 
most significantly upregulated. However, the PCB153-associated gene 
regulation pattern was unlike the patterns for PCB126 and TCDD, 
whose effects could be blocked by an AhR antagonist in vitro.
The inflammatory response was strongly induced in precursor cells 
and to a lesser degree in adipocytes, and this response was mediated 
through the AhR. The findings were confirmed in the rodent tissue 
and are congruent with epidemiologic studies. Caution is required in 
extending the findings to human health, however, because the rodent 
exposure regimen was dissimilar from typical human exposures. 
Nevertheless, this study highlights what may prove to be one of the 
major mechanisms by which POPs affect disease development.
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Optimizing Insecticide Resources
Global Trends in Vector Control
Although insecticides have helped lower worldwide rates of infectious 
disease, the use of these chemicals must be monitored and controlled to 
avoid pest resistance and minimize associated risks to human health and 
the environment. Researchers have conducted a comprehensive assess-
ment of trends in the global use of insecticides for vector-borne disease 
control over the last decade and found that the potential for overuse of 
pyrethroids could result in a loss of the effectiveness of long-lasting insec-
ticidal nets (LNs), which have been one of the most successful tools for 
controlling malaria to date [EHP 120(4):577–582; van den Berg et al.].
The research team analyzed data from 125 countries that used 
organochlorines, organophosphates, carbamates, and pyrethroids 
for vector control between 2000 and 2009. Application methods 
were classified as residual spraying (spraying interior and peripheral 
surfaces of houses), space spraying (spraying exterior spaces), treat-
ment of nets (not including factory manufacturing of LNs, which 
contain pyrethroids), and larviciding (treating aquatic breeding sites 
of mosquitoes with insecticides). The team conducted 2 analyses of 
insecticide use for each country, covering a 10-year and an annual 
average.
The main diseases targeted by insecticide use were malaria, den-
gue, leishmaniasis, and Chagas disease. The organochlorine DDT 
was by far the most used insecticide in terms of quantity (71%), with 
India accounting for most applications (82%) and African countries 
accounting for the rest. Globally the use of DDT has not changed 
substantially since the Stockholm Convention on Persistent Organic 
Pollutants was established in 2004, although use increased sharply in 
Africa until 2008. 
Pyrethroid use in residual and space spraying accounted for the 
greatest surface or area covered (81%), with most use occurring in 
the Americas, although an increase occurred in African countries. 
Global pyrethroid use has increased steadily since 2004, mainly 
due to increased use for residual spraying, a factor the authors warn 
could promote resistance among mosquitoes, negatively affecting 
the long-term effectiveness of treated bed nets. They warn that 
“in areas where resistance genes have already spread, immediate 
implementation of resistance management is required to preserve the 
effectiveness of available tools, including LNs.”
The main limitation of the study is countries’ potential lack of 
capacity for reporting insecticide use, especially regarding dengue 
control (which tends to be less structured than malaria control). 
Even so, the data collected can help guide global strategies on vector 
control and resistance management.
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A health officer in Kolkata, India, 
fumigates to prevent the spread of 
mosquito-borne diseases in 2005. 